1 / 4

Global Kidney Disease Market – Industry Trends and Forecast to 2029

Data Bridge Market Research analyses a growth rate in the global kidney disease market in the forecast period 2022-2029. The expected CAGR of the global kidney disease market tends to be around 5.50% in the mentioned forecast period. The market was valued at USD 96.72 billion in 2021, and it would grow up to USD 148.43 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient e

pawarmnk
Download Presentation

Global Kidney Disease Market – Industry Trends and Forecast to 2029

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Kidney Disease Market – Industry Trends and Forecast to 2029 The global kidney disease market is expected to witness significant growth during the forecast period. As per the reports of the CDC, it is expected that more than 37 million people in the U.S. suffer from CKD, whereas globally, more than 500 million people are affected. An increasing number of patients suffering from kidney failure is projected to drive the market. Data Bridge Market Research analyses a growth rate in the global kidney disease market in the forecast period 2022-2029. The expected CAGR of the global kidney disease market tends to be around 5.50% in the mentioned forecast period. The market was valued at USD 96.72 billion in 2021, and it would grow up to USD 148.43 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. https://www.databridgemarketresearch.com/reports/global-kidney-disease-market

  2. Report Description COVID-19 Impact on Global Kidney Disease Market             The growing cases of COVID-19 directly correlate with the growth of kidney-related diseases. For instance, as per the report published in 2021, titled "Acute Kidney Injury in COVID-19: 90 Days of the Pandemic in a Brazilian Public Hospital," 4–37% of COVID-19 cases involve the kidneys, and acute kidney diseases have an incidence of 50% among hospitalized COVID-19 patients. Thus, it has been found that the COVID-19 virus is having a major impact on the kidney of patients, which in turn, is expected to increase the burden of kidney disorders shortly and boost the market growth. Thus, COVID-19 had a major impact on the global kidney disease market. Recent Developments In October 2019, Fresenius Medical Care received breakthrough device designation by the U.S. FDA for its latest hemodialysis machine, which aims to stop blood clotting without using any medication. https://www.databridgemarketresearch.com/toc/?dbmr=global-kidney-disease-market

  3. Market Segmentation • Key players operating in the global kidney disease market include: • Pfizer Inc (U.S.) • AstraZeneca (U.K.) • Bristol-Myers Squibb Company (U.S.) • Allergan,Inc (Ireland) • Dr. Reddy's Laboratories Ltd (India) • Endo International plc (Ireland) • Teva Pharmaceutical Industries Ltd (Israel) • Sun Pharmaceutical Industries Ltd (India) • Mylan N.V. (U.S.) • Novartis AG (Switzerland) • Lupin (India) • CiplaInc (India) • Aurobindo Pharma (India) • https://www.databridgemarketresearch.com/reports/global-kidney-disease-market

  4. About Data Bridge Market Research An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth  the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Read Continue : http://databridgemarketresearch.com/about-us/ Contact Us : SopanGedam Sopan.gedam@databridgemarketresearch.com

More Related